{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:21:20Z","timestamp":1768321280712,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ejphar.2017.02.047","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T03:43:56Z","timestamp":1488339836000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Characterization of 6-methoxyflavanone as a novel anxiolytic agent: A behavioral and pharmacokinetic approach"],"prefix":"10.1016","volume":"801","author":[{"given":"Shehla","family":"Akbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazal","family":"Subhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasiara","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urooj","family":"Aman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khwaja","family":"Fawad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.E.","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.02.047_bib1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.biopha.2016.10.017","article-title":"6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain","volume":"84","author":"Akbar","year":"2016","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.047_bib2","series-title":"Diagnostic and statistical manual of mental disorders (DSM)","first-page":"143","author":"Association","year":"1994"},{"key":"10.1016\/j.ejphar.2017.02.047_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF00172966","article-title":"Benzodiazepine antagonist RO 15-1788 partly reverses some anxiolytic effects of ethanol in the mouse","volume":"95","author":"Belzung","year":"1988","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.ejphar.2017.02.047_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0166-4328(01)00452-1","article-title":"Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice","volume":"134","author":"Carola","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2017.02.047_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbr.2011.02.038","article-title":"Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice","volume":"221","author":"de Carvalho","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2017.02.047_bib6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/jm9904349","article-title":"GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology","volume":"43","author":"Chebib","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2017.02.047_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4088\/JCP.s.7002.05","article-title":"First-line pharmacotherapy approaches for generalized anxiety disorder","volume":"70","author":"Davidson","year":"2009","journal-title":"J. Clin. Psychiat."},{"key":"10.1016\/j.ejphar.2017.02.047_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.ne.15.030192.002033","article-title":"The role of the amygdala in fear and anxiety","volume":"15","author":"Davis","year":"1992","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2017.02.047_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/17460441.3.6.677","article-title":"Strategies to assess blood-brain barrier penetration","volume":"3","author":"Di","year":"2008","journal-title":"Expert Opin. Drug Disco."},{"key":"10.1016\/j.ejphar.2017.02.047_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02245750","article-title":"Effects of benzodiazepine agonist, inverse agonist and antagonist drugs in the mouse staircase test","volume":"102","author":"Emmanouil","year":"1990","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.ejphar.2017.02.047_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0091-3057(95)02171-X","article-title":"The influence of open arm ledges and maze experience in the elevated plus-maze","volume":"54","author":"Fernandes","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2017.02.047_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.neuropharm.2008.06.069","article-title":"Flavan-3-ol derivatives are positive modulators of GABAA receptors with higher efficacy for the \u03b1 2 subtype and anxiolytic action in mice","volume":"55","author":"Fernandez","year":"2008","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.ejphar.2017.02.047_bib13","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s11064-009-9969-9","article-title":"The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice","volume":"34","author":"Fernandez","year":"2009","journal-title":"Neurochem. Res"},{"key":"10.1016\/j.ejphar.2017.02.047_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ilar.43.4.244","article-title":"Guidelines for the design and statistical analysis of experiments using laboratory animals","volume":"43","author":"Festing","year":"2002","journal-title":"ILAR J."},{"key":"10.1016\/j.ejphar.2017.02.047_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00292-3","article-title":"Factors controlling measures of anxiety and responses to novelty in the mouse","volume":"125","author":"File","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2017.02.047_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-010-1873-0","article-title":"Measuring anxiety-and locomotion-related behaviours in mice: a new way of using old tests","volume":"211","author":"Fraser","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2017.02.047_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0006-8993(96)00517-3","article-title":"5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze","volume":"732","author":"Gonzalez","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2017.02.047_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0028-3908(99)00026-X","article-title":"Pharmacological studies on synthetic flavonoids: comparison with diazepam","volume":"38","author":"Griebel","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2017.02.047_bib19","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s11064-013-1157-2","article-title":"Modulation of ionotropic GABA receptors by 6-Methoxyflavanone and 6-Methoxyflavone","volume":"39","author":"Hall","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2017.02.047_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1037\/h0071444","article-title":"Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality","volume":"18","author":"Hall","year":"1934","journal-title":"J. Comp. Psychol."},{"key":"10.1016\/j.ejphar.2017.02.047_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00176484","article-title":"Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination","volume":"92","author":"Hodges","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2017.02.047_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainres.2013.07.045","article-title":"GABA-A receptor modulators alter emotionality and hippocampal theta rhythm in an animal model of long-lasting anxiety","volume":"1532","author":"Hoeller","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2017.02.047_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1021\/ci0200321","article-title":"3D-pharmacophores of flavonoid binding at the benzodiazepine GABAA receptor site using 4D-QSAR analysis","volume":"43","author":"Hong","year":"2003","journal-title":"J. Chem. Info Model. Sci."},{"key":"10.1016\/j.ejphar.2017.02.047_bib24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(24)29466-0","article-title":"Pentylenetetrazole-induced inhibition of recombinant \u03b3-aminobutyric acid type A (GABAA) receptors: mechanism and site of action","volume":"298","author":"Huang","year":"2001","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.ejphar.2017.02.047_bib25","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.bcp.2011.09.002","article-title":"3-Hydroxy-2\u2032-methoxy-6-methylflavone: a potent anxiolytic with a unique selectivity profile at GABAA receptor subtypes","volume":"82","author":"Karim","year":"2011","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.047_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.bjp.0706246","article-title":"Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells","volume":"145","author":"Kempuraj","year":"2005","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.047_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1025048802629","article-title":"The emotional brain, fear, and the amygdala","volume":"23","author":"LeDoux","year":"2003","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2017.02.047_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1146\/annurev.ne.17.030194.003033","article-title":"GABAA receptor channels","volume":"17","author":"Macdonald","year":"1994","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2017.02.047_bib29","doi-asserted-by":"crossref","first-page":"541-","DOI":"10.1006\/anbe.2002.4004","article-title":"Risk taking during exploration of a plus-maze is greater in adolescent than in juvenile or adult mice","volume":"64","author":"Macr\u0131\u0300","year":"2002","journal-title":"Anim. Behav."},{"key":"10.1016\/j.ejphar.2017.02.047_bib30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.bcp.2004.07.025","article-title":"Specific GABAA circuits in brain development and therapy","volume":"68","author":"Mohler","year":"2004","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.047_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pnpbp.2007.07.023","article-title":"Behavioral effects of 6-bromoflavanone and 5-methoxy-6,8-dibromoflavanone as anxiolytic compounds","volume":"32","author":"Ognibene","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiat"},{"key":"10.1016\/j.ejphar.2017.02.047_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1211\/0022357991772790","article-title":"Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds","volume":"51","author":"Paladini","year":"1999","journal-title":"J. Pharm. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.047_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.ejphar.2017.02.047_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00175182","article-title":"The staircase test: some evidence of nonspecificity for anxiolytics","volume":"89","author":"Pollard","year":"1986","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.ejphar.2017.02.047_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0014-2999(03)01272-X","article-title":"The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review","volume":"463","author":"Prut","year":"2003","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.047_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuropharm.2010.11.005","article-title":"Enhanced susceptibility to the GABA antagonist pentylenetetrazole during the latent period following a pilocarpine-induced status epilepticus in rats","volume":"60","author":"Rattka","year":"2011","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.ejphar.2017.02.047_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.chroma.2006.01.019","article-title":"Analytical separation and detection methods for flavonoids","volume":"1112","author":"de Rijke","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejphar.2017.02.047_bib38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0091-3057(95)00190-8","article-title":"Ethopharmacological analysis of the effects of putative \u2018anxiogenic\u2019agents in the mouse elevated plus-maze","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2017.02.047_bib39","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific \u03b3-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2017.02.047_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1037\/0735-7044.106.1.72","article-title":"NMDA lesions of the lateral and basolateral nuclei of the amygdala block and shock of sensitization of fear-potentiated startle","volume":"106","author":"Sananes","year":"1992","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.ejphar.2017.02.047_bib41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF00432023","article-title":"The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents","volume":"84","author":"Simiand","year":"1984","journal-title":"Psychopharmacol. (Berl.)"},{"key":"10.1016\/j.ejphar.2017.02.047_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2006-958058","article-title":"Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects","volume":"61","author":"Viola","year":"1995","journal-title":"Planta Med"},{"key":"10.1016\/j.ejphar.2017.02.047_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1527-3458.1999.tb00094.x","article-title":"Ligands of the GABAA receptor benzodiazepine binding site","volume":"5","author":"Wang","year":"1999","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2017.02.047_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0091-3057(94)90103-1","article-title":"Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea","volume":"47","author":"Wolfman","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2017.02.047_bib45","first-page":"29","article-title":"Determination of naringenin in rat plasma with the Culex\u00ae automated blood sampler coupled with liquid chromatography\/electrochemistry","volume":"4","author":"Xie","year":"2004","journal-title":"Asian J. Drug Metab. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.047_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0253-7613.40487","article-title":"Effect of Morus alba L.(mulberry) leaves on anxiety in mice","volume":"40","author":"Yadav","year":"2008","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.ejphar.2017.02.047_bib47","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tips.2009.05.007","article-title":"GABAergic analgesia: new insights from mutant mice and subtype-selective agonists","volume":"30","author":"Zeilhofer","year":"2009","journal-title":"Trends Pharmacol. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917301346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917301346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T21:54:46Z","timestamp":1750024486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917301346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":47,"alternative-id":["S0014299917301346"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.02.047","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of 6-methoxyflavanone as a novel anxiolytic agent: A behavioral and pharmacokinetic approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}